Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-13,500
Closed -$81K 7044
2014
Q4
$81K Sell
13,500
-3,000
-18% -$18.9K ﹤0.01% 5360
2014
Q3
$99K Hold
16,500
﹤0.01% 5338
2014
Q2
$116K Hold
16,500
﹤0.01% 5304
2014
Q1
$116K Sell
16,500
-39,000
-70% -$273K ﹤0.01% 5308
2013
Q4
$389K Buy
+55,500
New +$406K ﹤0.01% 4346

Other funds holding ABEV

Barclays's ABEV Position: Q1 2026 in Review

Barclays opened a new position in Ambev (ABEV) in Q1 2026: 682 shares worth $1.99K. The stake represents ﹤0.01% of the portfolio and ranks #4854 among its holdings. This is a return to the name: Barclays previously reported a position in ABEV as recently as Q3 2025.

Barclays first reported a position in ABEV in Q4 2013 and has held it in 42 quarters since. The position peaked at $12.9M in Q3 2015. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Barclays held 682 shares of Ambev worth $1.99K as of Q1 2026.
  • Ambev was a new Barclays position in Q1 2026.
  • Ambev made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4854 holding.
  • Barclays first reported a position in Ambev in Q4 2013 and has held it in 42 quarters since.
  • Barclays's Ambev position peaked at $12.9M in Q3 2015.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.